Clinic
Family Planning of South Central New York, INC.
Family Planning of South Central New York, INC. was paid $3.95M by Medicaid between Jan 2018 and Dec 2024, across 36 billing codes. Its largest line is 81025, — 19% of everything it billed.
33Billing provider infoFAMILY PLANNING OF SOUTH CENTRAL NEW YORK, INC.
ONEONTA, NY 13820
ONEONTA, NY 13820
33aNPI1033114004assigned 06/16/2005
33bProvider typeNon-Surgical Family Planning Clinic/Center
28Total paid$3.95M
24GClaims115,764
24DCodes billed36
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Non-Surgical Family Planning Clinic/Center providers in New York
Rank by total paid#2 of 6
Median peer was paid$462K
This provider vs. median8.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 11,655 | $644K | |
| 2019 | 18,488 | $634K | |
| 2020 | 19,992 | $733K | |
| 2021 | 20,255 | $609K | |
| 2022 | 16,901 | $513K | |
| 2023 | 16,786 | $472K | |
| 2024incomplete | 11,687 | $349K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 81025 | 19% | 29,082 | 18,342 | $732K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 17% | 6,706 | 6,355 | $669K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 12% | 13,949 | 11,361 | $492K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 9.2% | 8,647 | 8,582 | $364K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 8.0% | 10,616 | 10,146 | $315K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 7.5% | 3,042 | 3,011 | $296K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 7.0% | 2,701 | 2,514 | $277K |
| 88142 | 5.4% | 5,308 | 2,678 | $214K | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.7% | 903 | 899 | $107K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.4% | 7,484 | 7,408 | $94K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.6% | 686 | 667 | $65K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.4% | 436 | 436 | $54K |
24 more codes
| 36416 | 1.2% | 1,456 | $46K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 1,669 | $32K |
| 86703 | <1% | 2,218 | $31K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 1,065 | $31K |
| 87210 | <1% | 3,934 | $25K | |
| 86780 | <1% | 2,046 | $24K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 909 | $16K |
| 87510 | <1% | 1,238 | $11K | |
| 87806 | <1% | 567 | $10K | |
| 85018 | <1% | 2,391 | $8K | |
| 58301 | <1% | 99 | $7K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,126 | $6K |
| 87660 | <1% | 1,099 | $5K | |
| 87480 | <1% | 1,021 | $5K | |
| 81002 | <1% | 4,343 | $5K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 38 | $4K |
| 58300 | <1% | 36 | $2K | |
| S4993 | Contraceptive pills for birth control | <1% | 194 | $1K |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | <1% | 183 | $1K |
| 99051 | <1% | 39 | $395.36 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 452 | $363.24 |
| G0433 | Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening | <1% | 20 | $303.81 |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 0% | 12 | $0.00 |
| 87086 | Culture, bacterial; quantitative colony count, urine | 0% | 49 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialARTALE, THOMAS (DIRECTOR OF FINANCE)